UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 19, pp. 1792 - 1802
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Medical sciences | Epidemiology | Humans | Middle Aged | Proportional Hazards Models | Neoplasms - mortality | Male | Neoplasms - prevention & control | Cause of Death | Incidence | Neoplasms - complications | Cardiovascular Diseases - complications | Diabetes Mellitus - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Denmark - epidemiology | Diabetes Complications - epidemiology | Adult | Female | Aged | Care and treatment | Usage | Medical examination | United States | Patient outcomes | Mortality | Statistics | Cancer patients | Denmark | Dosage and administration | Drug therapy | Health aspects | Statins | Methods | Cancer | Medical research | Lymphatic system | Clinical trials | Death | Diagnosis | Cholesterol | Metastases | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 11/2016, Volume 316, Issue 19, pp. 1997 - 2007
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Primary Prevention | Age Factors | Dyslipidemias - complications | Risk Assessment | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Mass Screening - standards | Male | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Aged, 80 and over | Cardiovascular Diseases - mortality | Adult | Female | Aged | Dyslipidemias - diagnosis | Dyslipidemias - diet therapy | Prevention | Usage | Dosage and administration | Adults | Cardiovascular diseases | Health aspects | Statins | Disease prevention | Cardiovascular disease | Index Medicus | Abridged Index Medicus
Journal Article
JAMA ophthalmology, ISSN 2168-6165, 09/2013, Volume 131, Issue 11, pp. 1427 - 1434
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | United States - epidemiology | Cataract - chemically induced | Military Medicine | Lipoproteins, HDL - blood | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Male | Cataract - epidemiology | Incidence | Propensity Score | Drug Prescriptions - statistics & numerical data | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cholesterol, LDL - blood | Female | Retrospective Studies | Odds Ratio | Cohort Studies | Databases, Factual | Prevention | Cataract | Cohort analysis | Usage | Cataract in old age | Aged | Health aspects | Risk factors | Statins | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system | Medicin och hälsovetenskap
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 10/2007, Volume 176, Issue 8, pp. 742 - 747
FVC | Lung function | FEV | Statins | Smoking | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Biological and medical sciences | Intensive care medicine | Medical sciences | Chronic obstructive pulmonary disease, asthma | Emergency and intensive respiratory care | Pneumology | Forced Expiratory Volume - drug effects | Forced Expiratory Volume - physiology | Humans | Middle Aged | Male | Vital Capacity - drug effects | Smoking - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Smoking - physiopathology | Vital Capacity - physiology | Aged, 80 and over | Adult | Aged | Longitudinal Studies | Index Medicus | Abridged Index Medicus | FEV1 | lung function | B. Chronic Obstructive Pulmonary Disease | statins | smoking
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 06/2020, Volume 26, Issue 6, pp. 1243 - 1250
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Influenza vaccines | National health insurance | Analysis | Vaccination | Influenza | Online databases | Research | Statins | Pneumonia | Cardiovascular disease | Hospitalization | Vaccines | Hospitals | Illnesses | Older people | Population | Diabetes | Age | Ambulatory care | Index Medicus | influenza | viruses | hospitalization | critical illness | vaccines | Taiwan | Statin Use and Influenza Vaccine Effectiveness in Persons ≥ 65 Years of Age, Taiwan | vaccine-preventable diseases | respiratory diseases
Journal Article
Journal of hepatology, ISSN 0168-8278, 2015, Volume 63, Issue 3, pp. 705 - 712
Gastroenterology and Hepatology | PNPLA3 | Statin | NASH | Non-alcoholic fatty liver disease | Non-alcoholic steatohepatitis | Cholesterol | Steatosis | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Non-alcoholic Fatty Liver Disease - pathology | Liver - pathology | Membrane Proteins - genetics | Humans | Middle Aged | Logistic Models | Male | Risk | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Non-alcoholic Fatty Liver Disease - chemically induced | Biopsy | Adult | Female | Aged | Lipase - genetics | Statins | Index Medicus
Journal Article
Thrombosis and haemostasis, ISSN 0340-6245, 2015, Volume 114, Issue 3, pp. 546 - 557
D-dimer | Statin | Fibrinolysis | Coagulation | Dyslipidemias - blood | Dyslipidemias - drug therapy | Blood Coagulation - drug effects | Time Factors | Fibrin Fibrinogen Degradation Products - analysis | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Anticoagulants - therapeutic use | Treatment Outcome | Biomarkers - blood | Dyslipidemias - diagnosis | Randomized Controlled Trials as Topic
Journal Article
Nutrition (Burbank, Los Angeles County, Calif.), ISSN 0899-9007, 2016, Volume 32, Issue 11-12, pp. 1179 - 1192
Gastroenterology and Hepatology | Atherogenic dyslipidemia | Lipids | Functional foods | Nutraceuticals | Life Sciences & Biomedicine | Nutrition & Dietetics | Science & Technology | Dietary Fats, Unsaturated - therapeutic use | Dyslipidemias - drug therapy | Stilbenes - therapeutic use | Humans | Evidence-Based Medicine | Hibiscus | Dyslipidemias - blood | Dietary Fiber - therapeutic use | Lipids - blood | Anthocyanins - therapeutic use | Probiotics - therapeutic use | Garlic | Hypolipidemic Agents - therapeutic use | Berberine - therapeutic use | Dietary Supplements | Phytosterols - therapeutic use | Dyslipidemias - diet therapy | Biological Products - therapeutic use | Medical colleges | Family medicine | Analysis | Statins | Cardiovascular agents | Studies | Plasma | Vegetable oils | Sterols | Natural products | Atherosclerosis | Clinical trials | Low density lipoprotein | Cholesterol | Functional foods & nutraceuticals | Index Medicus
Journal Article